Operating Income (Loss) of RayzeBio, Inc. from 30 Sep 2022 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
RayzeBio, Inc. quarterly Operating Income (Loss) in USD history and change rate from 30 Sep 2022 to 30 Sep 2023.
  • RayzeBio, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2023 was $21,651,000, a 3.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)

RayzeBio, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $21,651,000 -$701,000 -3.3% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $20,950,000 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.